| 201 |
11020127 | Protease inhibitor-induced carbamazepine toxicity. | 2000 Jul-Aug |
2 |
| 202 |
10082072 | Drug interactions of HIV protease inhibitors. | 1999 Feb |
1 |
| 203 |
10421617 | Potent inhibition of the cytochrome P-450 3A-mediated human liver microsomal metabolism of a novel HIV protease inhibitor by ritonavir: A positive drug-drug interaction. | 1999 Aug |
2 |
| 204 |
10589373 | Clinical pharmacokinetics of clarithromycin. | 1999 Nov |
1 |
| 205 |
9585795 | The effect of multiple doses of ritonavir on the pharmacokinetics of rifabutin. | 1998 Apr |
1 |
| 206 |
9616191 | Metabolism of the human immunodeficiency virus protease inhibitors indinavir and ritonavir by human intestinal microsomes and expressed cytochrome P4503A4/3A5: mechanism-based inactivation of cytochrome P4503A by ritonavir. | 1998 Jun |
5 |
| 207 |
9812178 | Ritonavir. Clinical pharmacokinetics and interactions with other anti-HIV agents. | 1998 Oct |
6 |
| 208 |
9876810 | Potential interaction involving warfarin and ritonavir. | 1998 Dec |
1 |
| 209 |
9084785 | Saquinavir pharmacokinetics alone and in combination with ritonavir in HIV-infected patients. | 1997 Mar 15 |
2 |
| 210 |
9278209 | Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir. | 1997 Aug |
2 |
| 211 |
9486958 | HIV protease inhibitors, saquinavir, indinavir and ritonavir: inhibition of CYP3A4-mediated metabolism of testosterone and benzoxazinorifamycin, KRM-1648, in human liver microsomes. | 1997 Dec |
2 |
| 212 |
8613951 | Cytochrome P450-mediated metabolism of the HIV-1 protease inhibitor ritonavir (ABT-538) in human liver microsomes. | 1996 Apr |
2 |